Patricio S. Espinosa: Anticoagulation Is Not an Absolute Contraindication to Amyloid Therapy
Patricio S. Espinosa, Chief of Neurology and Institute Director at Espinosa Neuroscience Institute, shared a post on X:
”MYTH vs FACT: Amyloid Therapies & Anticoagulants
There is a common misconception that patients on anticoagulants (blood thinners) cannot receive amyloid-targeted therapies such as Kisunla (donanemab) and Leqembi (lecanemab).
MYTH:
Patients on anticoagulation are not candidates for amyloid therapies.
FACT:
With careful patient selection, strict adherence to protocols, and close monitoring, patients on anticoagulants can safely receive these therapies.
At Espinosa Neuroscience Institute, we have treated patients on anticoagulation with amyloid-targeted therapies without complications, by following:
- Rigorous MRI screening protocols
- Close monitoring for ARIA (Amyloid-Related Imaging Abnormalities)
- Individualized risk–benefit assessment
- Coordination of care across specialties
The key is not exclusion – it’s precision medicine.
These therapies are transforming how we treat mild cognitive impairment and early Alzheimer’s disease, and we should not deny patients access based on outdated assumptions.
Bottom line:
Anticoagulation is not an absolute contraindication – it requires expert management and protocol-driven care.”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?
-
Jun 23, 2026, 17:33Maité Mulkers: Time is Brain, and One Reason is That a Thrombus Develops Over Time
-
Jun 23, 2026, 17:32Dhargam Aljebouri: Honoured to Be Part of the Young Professionals Breakfast at ISBT 2026
-
Jun 23, 2026, 17:27Dianne E. van der Wal: Phenotype and Activation of the Endothelium in ET at ISTH 2026